Industries > Pharma > Global Infectious Disease Diagnostics Market Forecast 2017-2027

Global Infectious Disease Diagnostics Market Forecast 2017-2027

Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography

PUBLISHED: 27 September 2017
PAGES: 142
PRODUCT CODE: PHA0243

Clear
WOOCS 2.2.1

Infectious Disease Diagnostics – our new study reveals trends, R&D progress, and predicted revenues
Where is the Infectious Disease Diagnostics market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover how to stay ahead
Our 142-page report provides 83 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Infectious Disease Diagnostics market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects
• In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
• You find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the infectious disease diagnostics market, with forecasts for 5 Diseases, 4 Techniques and 3 End Users, each forecasted at a global level.

Global Infectious Disease Diagnostic Market by Disease Type
• HIV/AIDS
• Hepatitis
• Tuberculosis
• Malaria
• Chlamydia

Global Infectious Disease Diagnostic Market by Technique
• Immunoassay
• Molecular Diagnostics
• POC/Rapid Diagnosis
• Microbiology

Global Infectious Disease Diagnostic Market by End User
• Hospitals
• Clinical Laboratories
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 11 leading national markets:
• US
• Germany
• The UK
• Italy
• Spain
• France
• Japan
• Brazil
• China
• India
• Russia

Global Infectious Disease Diagnostics Market Forecast 2017-2027

The report also includes profiles and for some of the leading companies in the Infectious Disease Diagnostics market, with a focus on this segment of these companies’ operations.

There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, China, India and the US in particular, will continue to achieve high revenue growth to 2027.

Leading companies and the potential for market growth
Overall world revenue for Infectious Disease Diagnostics will surpass $13bn in 2017, our work calculates. We predict strong revenue growth through to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the Infectious Disease Diagnostics Market report helps you
In summary, our 142-page report provides you with the following knowledge:
• Revenue forecasts to 2027 for 3 segmentations of the Infectious Disease Diagnostics market, with forecasts for 5 Disease Types, 4 Techniques and 3 End Users – discover the industry’s prospects, finding the most lucrative places for investments and revenues
• Revenue forecasts to 2027 for 11 key national markets – See forecasts for the infectious disease diagnostics market in the US, Brazil, Germany, France, the UK, Italy, Spain, China, India, Russia and Japan
• Discussion of what stimulates and restrains companies and the market
• Prospects for established firms and those seeking to enter the market
– including company profiles for 9 of the major companies involved in the Infectious Disease Diagnostics market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else
With our newly updated report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.

Visiongain’s study is for everybody needing commercial analyses for the Infectious Disease Diagnostics market and leading companies. You will find data, trends and predictions.

Get our report today Global Infectious Disease Diagnostics Market Forecast 2017-2027: Revenue Prospects by Disease Type (HIV/AIDS, Hepatitis, Tuberculosis, Malaria, Chlamydia), Technique (Immunoassay, Molecular Diagnostics, POC/Rapid Diagnosis, Microbiology), End User (Hospitals, Clinical Laboratories, Others) and Geography.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Infectious Disease Diagnostics Market Forecast 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Infectious Disease Diagnostics Market Forecast 2017-2027


Latest Pharma news

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

READ

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

READ

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

READ

Visiongain Publishes Protein Labelling Reagents for Research Use Only (RUO) Market Report 2021-2031

Increasing investment in R&D for proteomics research, by both public and private organizations, is one of the major contributors to the growth of the protein labelling reagents market. The increasing prevalence of chronic diseases is also expected to contribute to the growth of this market.

05 May 2021

READ

Categories